Pharmaceutical Disruption: Are Compounding Pharmacies a Friend or Foe?
Authors:
Michael Lombardo, PharmD, PhD
Cort Hepler
1. Introduction
In the dynamic landscape of drug development and distribution, compounding pharmacies have come to play an important role in addressing unique patient needs. However, their presence in the market can also disrupt traditional pharmaceutical models, as recent controversies have shown. And while they may not directly participate in drug development, their influence on drug commercialization, pricing strategies, and regulatory frameworks could become increasingly significant.
2. The Role of Compounding Pharmacies in the Healthcare Market
Compounding pharmacies help fulfill critical needs in the pharmaceutical market principally by creating personalized medications tailored to individual patient needs and plugging gaps in supply. Their key activities include:
- Dosage Modification: Adjusting drug concentrations to meet specific therapeutic requirements.
- Formulation Alteration: Transforming medications into alternative dosage forms, such as liquids or powders, to improve patient compliance.
- Allergen Removal: Customizing medications to eliminate excipients that may cause adverse reactions.
- Combination Therapies: Crafting formulations that integrate multiple active ingredients for complex medical conditions.
- Drug Shortages: Mitigating drug shortages during public health crises or supply chain disruptions.
These services are particularly valuable in pediatrics, geriatrics, and for patients with rare diseases or unique sensitivities, where mass-produced medications may not provide adequate solutions.
3. Types of Compounding Pharmacies
Compounding Pharmacies are classified as one of two types based on their activities, although some companies operate as both simultaneously. The distinction between 503A and 503B compounding pharmacies is an essential aspect of the regulatory framework governing compounding practices in the United States. Both types of compounding pharmacies operate under the framework established by the Drug Quality and Security Act (DQSA) of 2013, but their roles, requirements, and capabilities differ significantly.
503A Compounding Pharmacies
503A compounding pharmacies are traditional compounding facilities that primarily serve individual patients based on specific prescriptions from licensed healthcare providers. Their operations focus on creating customized medications to meet the unique needs of patients.
Key Characteristics:
- Patient-Specific Prescriptions: Medications are compounded only after receiving a valid prescription for an individual patient.
- Regulatory Oversight: Governed primarily by state pharmacy boards with limited additional oversight by the FDA.
- Exemptions: 503A pharmacies are exempt from certain FDA requirements, such as pre-market approval, Current Good Manufacturing Practices (cGMP), and mandatory labeling for large-scale manufacturers.
- Customization: Focuses on small-batch production tailored to individual needs, such as adjusting dosage forms, removing allergens, or creating pediatric-friendly formulations.
- Limitations on Bulk Drug Substances: May use only bulk drug substances listed on the FDA's approved list or deemed necessary based on clinical need.
https://www.alacrita.com/whitepapers/compounding-pharmacies-drug-development-implications
Download '.pdf' Format of the whitepaper.
